Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
Clinical trial NCT02263105 · COMPLETED
Trial details
- NCT number
- NCT02263105
- Sponsor
- Huashan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-05-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.